Related Experiment Video

Updated: May 13, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Involvement of STAT3 in immune evasion during lung tumorigenesis

Hiroshi Kida1, Shoichi Ihara, Atsushi Kumanogoh

  • 1Department of Respiratory Medicine, Allergy and Rheumatic Diseases; Osaka University Graduate School of Medicine; Suita, Osaka, Japan.

Oncoimmunology
|March 14, 2013
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) in tumor cells suppresses antitumor immunity and promotes resistance to natural killer (NK) cell attacks during lung cancer development.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Tumor cells can evade immune surveillance through various mechanisms.
  • Signal transducer and activator of transcription 3 (STAT3) is a key signaling molecule implicated in cancer progression.

Purpose of the Study:

  • To investigate the role of STAT3 expressed by tumor cells in modulating antitumor immunity during lung tumorigenesis.
  • To elucidate the specific mechanisms by which STAT3 influences immune responses and tumor cell vulnerability.

Main Methods:

  • Carcinogen-induced lung tumorigenesis model in mice.
  • Analysis of STAT3 expression in tumor cells.
  • Assessment of chemokine production and MHC molecule expression.
  • Evaluation of natural killer (NK) cell-mediated cytotoxicity against tumor cells.

Main Results:

  • Tumor cell-expressed STAT3 was found to inhibit the production of pro-inflammatory chemokines.
  • STAT3 suppressed the expression of MHC Class I chain-related gene A.
  • Conversely, STAT3 enhanced the expression of MHC class I molecules on tumor cells.
  • These effects collectively promoted tumor cell resistance to NK cell cytotoxicity.

Conclusions:

  • STAT3 in tumor cells plays a critical role in blunting antitumor immunity during lung cancer.
  • STAT3 contributes to immune evasion by altering the tumor microenvironment and promoting resistance to NK cell killing.
Keywords:
MHC Class IMICANK cellSTAT3antitumor immunitylungtumorigenesis

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...